Nebulized Lidocaine to Prevent Cough at Emergence From Anesthesia

Last updated: June 26, 2019
Sponsor: Mongi Slim Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pharyngitis

Treatment

N/A

Clinical Study ID

NCT04000633
lidocaïne cough prevention
  • Ages > 18
  • All Genders

Study Summary

our study aimed to evaluate the effect of nebulized lidocaine to decrease the incidence of cough and sore throat after extubation after surgeries requiring endotracheal intubation.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age>18 years

  • ASA status I or II

Exclusion

Exclusion Criteria:

  • Unexpected difficult laryngoscopy

  • Surgery>3 hours

Study Design

Total Participants: 80
Study Start date:
June 01, 2019
Estimated Completion Date:
December 31, 2019

Study Description

our study aimed to evaluate the effect of nebulized lidocaine to decrease the incidence of cough and sore throat after extubation after surgeries requiring endotracheal intubation.

This randomized controlled study will compare the effect of Lidocaine and placebo nebulization in the immediate pre operative period in order to evaluate the effectiveness in reducing post extubation cough and sore throat.

Connect with a study center

  • Mongi Slim Hospital

    La Marsa, Tunis 2046
    Tunisia

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.